» Articles » PMID: 20807774

Gene Expression Profiles Linked to AT1 Angiotensin Receptors in the Kidney

Overview
Date 2010 Sep 3
PMID 20807774
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To characterize gene expression networks linked to AT(1) angiotensin receptors in the kidney, we carried out genome-wide transcriptional analysis of RNA from kidneys of wild-type (WT) and AT(1A) receptor-deficient mice (KOs) at baseline and after 2 days of angiotensin II infusion (1,000 ng·kg(-1)·min(-1)). At baseline, 405 genes were differentially expressed (>1.5×) between WT and KO kidneys. Of these, >80% were upregulated in the KO group including genes involved in inflammation, oxidative stress, and cell proliferation. After 2 days of angiotensin II infusion in WT mice, expression of ≈805 genes was altered (18% upregulated, 82% repressed). Genes in metabolism and ion transport pathways were upregulated while there was attenuated expression of genes protective against oxidative stress including glutathione synthetase and mitochondrial superoxide dismutase 2. Angiotensin II infusion had little effect on blood pressure in KOs. Nonetheless, expression of >250 genes was altered in kidneys from KO mice during angiotensin II infusion; 14% were upregulated, while 86% were repressed including genes involved in immune responses, angiogenesis, and glutathione metabolism. Between WT and KO kidneys during angiotensin II infusion, 728 genes were differentially expressed; 10% were increased and 90% were decreased in the WT group. Differentially regulated pathways included those involved in ion transport, immune responses, metabolism, apoptosis, cell proliferation, and oxidative stress. This genome-wide assessment should facilitate identification of critical distal pathways linked to blood pressure regulation.

Citing Articles

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons.

Franco R, Serrano-Marin J, Navarro G, Rivas-Santisteban R Antioxidants (Basel). 2023; 12(10).

PMID: 37891948 PMC: 10604245. DOI: 10.3390/antiox12101869.


Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of "Vascular Memory".

Pothen L, Verdoy R, De Mulder D, Esfahani H, Farah C, Michel L Front Cardiovasc Med. 2022; 9:854361.

PMID: 35360022 PMC: 8964264. DOI: 10.3389/fcvm.2022.854361.


Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis.

Dubina M Front Med (Lausanne). 2022; 8:776903.

PMID: 35096872 PMC: 8789648. DOI: 10.3389/fmed.2021.776903.


Pathogenesis-based preexposure prophylaxis associated with a low risk of SARS-CoV-2 infection in healthcare workers at a designated COVID-19 hospital: a pilot study.

Dubina M, Gomonova V, Taraskina A, Vasilyeva N, Sayganov S BMC Infect Dis. 2021; 21(1):536.

PMID: 34098889 PMC: 8182762. DOI: 10.1186/s12879-021-06241-1.


When Less or More Isn't Enough: Renal Maldevelopment Arising From Disequilibrium in the Renin-Angiotensin System.

Almeida L, Coimbra T Front Pediatr. 2019; 7:296.

PMID: 31380328 PMC: 6650528. DOI: 10.3389/fped.2019.00296.


References
1.
Di Cunto F, Calautti E, Hsiao J, Ong L, Topley G, Turco E . Citron rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein Citron. J Biol Chem. 1998; 273(45):29706-11. DOI: 10.1074/jbc.273.45.29706. View

2.
Schiff D, Purow B . Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas. Nat Rev Neurol. 2009; 5(6):303-4. DOI: 10.1038/nrneurol.2009.57. View

3.
Mehta P, Griendling K . Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2006; 292(1):C82-97. DOI: 10.1152/ajpcell.00287.2006. View

4.
Ryan M, Didion S, Mathur S, Faraci F, Sigmund C . Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension. 2004; 43(5):1074-9. DOI: 10.1161/01.HYP.0000123074.89717.3d. View

5.
Reckelhoff J, Romero J . Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol. 2003; 284(4):R893-912. DOI: 10.1152/ajpregu.00491.2002. View